Thomas Stankovich Net Worth & Insider Trades
Thomas Stankovich - Chief Financial Officer, Reshape Lifesciences Inc
What is Thomas Stankovich's Net Worth?
The current estimated net worth of Reshape Lifesciences Inc's Chief Financial Officer, Thomas Stankovich, is estimated to be about $562.34K . Thomas Stankovich owns about 22,949 units of Reshape Lifesciences Inc common stock. In the last 3 years at Reshape Lifesciences Inc, Thomas Stankovich has sold an estimated value of $276.06K worth.
What is Thomas Stankovich's Past Insider Trading?
Thomas Stankovich's largest purchase order was 15,000 units , worth over $51.44K on August 31, 2021. Thomas Stankovich's largest sale order was 48,366 units , worth over $139.78K on September 17, 2021. In total, Thomas Stankovich has made about 26 transactions over 3 years of their time at Reshape Lifesciences Inc. Thomas Stankovich usually trades in November and August, with the busiest year in 2022. The most recent transaction was a sale order of 435 units , worth over $386.48 on November 8, 2023.
Attention insiders: Dive deeper into market movements and stay ahead of the curve with Benzinga Pro! From up-to-the-second news to audio squawks and interactive data tools, it's everything you need to supercharge your trading strategy. Experience the Benzinga Pro advantage today and transform the way you trade with our exclusive free trial!
Thomas Stankovich
Date Range: All Time
Ticker
|
Type
|
Value
|
Price per Share
|
Shares
|
Filing Date
| ||
|---|---|---|---|---|---|---|---|
| No matching records found | |||||||
InsideArbitrage
What is Thomas Stankovich's' Mailing Address?
- Mailing address is 1001 Calle Amanecer San Clemente CA 92673 CA
Reshape Lifesciences Inc Executive Compensation
Name |
Year
|
Salary
|
Bonus
|
Stock Awards
|
Option Awards
|
Other Earnings Plans or Compensations
|
Other Compensation
|
Total
|
|---|---|---|---|---|---|---|---|---|
| William Plovanic | 2019 | $422,917 | $241,000 | - | $290,708 | - | $994 | $955,619 |
| William Plovanic | 2018 | $400,000 | $155,000 | $127,350 | $381,710 | - | $949 | $1,065,009 |
| Andrew Rasdal | 2019 | $325,000 | - | $200,001 | - | - | $994 | $525,995 |
| Andrew Rasdal | 2018 | $650,000 | $520,000 | - | $1,145,130 | - | $978 | $2,316,108 |
| Mark Brister | 2019 | $367,500 | $35,000 | - | $139,180 | - | $994 | $542,674 |
| Kelly Huang | 2019 | $202,331 | - | - | $376,560 | - | $277,491 | $856,382 |
| Kelly Huang | 2018 | $432,000 | - | $183,950 | $305,368 | $199,800 | $4,242 | $1,125,360 |
| Amy Vandenberg | 2019 | $367,500 | $35,000 | - | $136,028 | - | $994 | $539,522 |
| No matching records found | ||||||||
Source: https://www.sec.gov/Archives/edgar/data/1427570/000142757020000051/obln2020def14a.htm
What are Reshape Lifesciences Inc's Past Insider Trades?
Reshape Lifesciences Inc's most recent insider trade came on November 8, 2023 by Thomas Stankovich who sold 435 units worth $386.48 . In the last 6 years, insiders at Reshape Lifesciences Inc have sold an estimated value of $16.12M and bought an estimated value of $1.43M worth of shares. Insider trading is most common in September, with the busiest year in 2022. The most active traders at the company are Armistice Capital Llc, Steven Boyd, and Armistice Capital Master Fund Ltd .
ReShape Lifesciences Inc. Insider Trades
Date Range: All Time
Insider Names
|
Type
|
Value
|
Price per Share
|
Shares
|
Filing Date
| ||
|---|---|---|---|---|---|---|---|
| No matching records found | |||||||